相关实验视频
Updated: Jan 18, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.0K
帕金森病和基本患者的定向深度大脑刺激编程:一个基于机构的研究
Maria C Moreno-Escobar1,2, Robin Elkins3, Ann Murray1,2
1Neurology, West Virginia University, Morgantown, USA.
Cureus
|September 8, 2025
概括
定向深度大脑刺激 (DBS) 编程有效地管理帕金森氏症.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 生物医学工程 生物医学工程
背景情况:
- 深度大脑刺激 (DBS) 是帕金森病 (PD) 和基本震 (ET) 的关键治疗方法.
- 定向引线通过启用子段刺激来提供对DBS的高级控制,从而可能提高效率并减少副作用.
研究的目的:
- 评估定向编程在PD和ET患者的第三级护理环境中的利用和影响.
- 评估采用定向刺激的原因及其对临床结果的影响.
主要方法:
- 对12名PD患者 (STN植入物) 和13名ET患者 (VIM植入物) 接受方向导向的医疗记录的回顾性审查.
- 评估临床参数使用Fahn-Tolosa-Marin (FTM) 尺度用于ET和统一帕金森病评级尺度 (UPDRS) 用于PD,手术前和后.
- 分析编程参数和转向定向刺激的原因.
主要成果:
- 观察到高度利用定向编程:92%的PD患者和92%的ET患者至少在一侧使用它.
- 使用定向编程的主要原因包括避免副作用 (58%PD,64%ET) 和改善治疗效益 (25%PD,33%ET).
- 定向配置导致ET患者的震控制得到改善.
结论:
- 定向编程在管理PD和ET患者中得到了广泛的应用.
- 定向刺激通过最大限度地减少副作用和改善治疗结果来提高疗效.
- 这些发现支持早期采用PD和ET管理的定向编程.
更多相关视频
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.3K
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
15.3K
相关概念视频
Parkinson's Disease: Treatment
995
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K